<DOC>
	<DOCNO>NCT01331863</DOCNO>
	<brief_summary>- First study ( BRONC-ART ) The purpose prospective study evaluate 90-day morbidity mortality rate bronchial transplantation use cryopreserved aortic allograft proximal lung cancer surgery . The investigator hypothesize stage 1-2 surgical innovation could safe effective order reduce 90-day morbidity mortality rate compare observed pneumonectomy , especially factor present : age &gt; 70 year , right side , neoadjuvant chemoradiotherapy . - Current study ( TRACHEO BRONC-ART ) The BRONC-ART study extend major ( malignant benign ) lesion trachea require airway transplantation . For patient , resection follow direct end end anastomosis possible high risk .</brief_summary>
	<brief_title>Airway and/or Pulmonary Vessels Transplantation</brief_title>
	<detailed_description>Surgery remain best option curative treatment early stage Non-Small Cell Lung Cancer ( NSCLC ) . Peripheral tumor usually resect use lobectomy low 90-day morbidity mortality rate ( 2 % ) . Central NSCLC often require pneumonectomy high 90-day morbidity mortality rate ( 24 % ) , especially factor present : age &gt; 70 year , right side , neoadjuvant chemoradiotherapy . On hand , bronchoplastic lobectomy propose order avoid pneumonectomy . However , fifty year first description , bronchoplastic lobectomy remain uncommon ( &lt; 1 % pulmonary resection ) . This could explain technical difficulty show potential interest bronchial substitute . In 10-year research phase sheep model ( n=108 ) , demonstrate aortic graft could valuable substitute tracheobronchial replacement . We observe progressive transformation aortic tissue airway tissue comprise epithelium regenerate cartilage . The technique extend clinical tracheal replacement u others encourage result . We propose evaluate feasibility use stent-supported cryopreserved aortic allograft bronchial substitute prevent pneumonectomy associate high mortality rate NSCLC surgery . Primary outcome 90-day mortality . Secondary outcome postoperative complication , 90-day morbidity . This prospective open study include 20 30 patient accord eligibility criterion ( see ) . The operation consist curative resection NSCLC follow replacement bronchial segment use cryopreserved allograft order re-implant functional pulmonary lobe . A stent place graft prevent airway collapse . -Current study ( TRACHEO BRONC-ART ) The BRONC-ART study extend major ( malignant benign ) lesion trachea require airway transplantation . For patient , resection follow direct end end anastomosis possible high risk .</detailed_description>
	<mesh_term>Tracheal Stenosis</mesh_term>
	<mesh_term>Tracheal Neoplasms</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>patient age â‰¥18 year patient capable give consent carry medical research procedure patient proximal Lung Cancer ( LC ) require surgical resection ( carinal resection , pneumonectomy , bronchoplastic lobectomy ) neoadjuvant chemotherapy adequate preoperative lung function test patient proximal LC require pneumonectomy without adequate preoperative lung function test patient extended lesion malignant benign trachea without bronchitic lesion therapeutic impasse . patient old 70 year proximal LC require pneumonectomy decision make multidisciplinary team patient information consent patient age &lt; 18 year patient capable give consent carry medical research procedure patient proximal peripheral LC require simple lobectomy patient unresectable LC major local involvement , N3 and/or M1 status ( exception unique resectable brain metastasis ) patient tracheal lesion isolate simple resection anastomosis tracheal iodine allergy preoperative evaluation allow simple lobectomy patient affiliate French Social Security System</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Bronchial disease</keyword>
	<keyword>Lung cancer surgery</keyword>
	<keyword>Aorta/aortic Allograft</keyword>
	<keyword>homograft</keyword>
	<keyword>Tracheal disease</keyword>
	<keyword>Benign</keyword>
	<keyword>Malignant</keyword>
</DOC>